UNIGE document Scientific Article
previous document  unige:1321  next document
add to browser collection

Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study

Coll, Oriol
Barlow, Patricia
Aebi-Popp, Karoline
Martinez de Tejada, Begoña
Published in AIDS. 2008, vol. 22, no. 15, p. 2013-7
Abstract OBJECTIVE: To assess the impact of HIV infection on the reliability of the first-trimester screening for Down syndrome, using free beta-human chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency, and of the second-trimester screening for neural tube defects, using alpha-fetoprotein. PATIENTS AND METHODS: Multicentre study comparing the multiples of the median of markers for Down syndrome and neural tube defect screening among 214 HIV-infected pregnant women and 856 HIV-negative controls undergoing a first-trimester Down syndrome screening test, and 209 HIV-positive women and 836 HIV-negative controls with a risk evaluation for neural tube defect. The influence of treatment, chronic hepatitis and HIV disease characteristics were also evaluated. RESULTS: Multiples of the median medians for pregnancy-associated plasma protein-A and beta-human chorionic gonadotrophin were lower in HIV-positive women than controls (0.88 vs. 1.05 and 0.84 vs. 1.09, respectively; P < 0.005), but these differences had no impact on risk estimation; no differences were observed for the other markers. No association was found between HIV disease characteristics, antiretroviral treatment use at the time of screening or chronic hepatitis and marker levels. CONCLUSION: Screening for Down syndrome during the first trimester and for neural tube defect during the second trimester is accurate for HIV-infected women and should be offered, similar to HIV-negative women.
Keywords AdultBiological Markers/bloodChorionic Gonadotropin, beta Subunit, Human/bloodDown Syndrome/diagnosisFemaleFetal Diseases/diagnosisHIV Infections/bloodHumansMass Screening/methodsNeural Tube Defects/diagnosisNuchal Translucency MeasurementPregnancyPregnancy Complications, Infectious/bloodPregnancy-Associated Plasma Protein-A/analysisPrenatal Diagnosis/methodsAlpha-Fetoproteins/analysis
PMID: 18784463
Full text
Article (Author postprint) (105 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Swiss HIV Cohort Study
Swiss Mother and Child HIV Cohort Study
(ISO format)
BROSSARD, Philippe et al. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study. In: AIDS, 2008, vol. 22, n° 15, p. 2013-7. https://archive-ouverte.unige.ch/unige:1321

232 hits

1 download


Deposited on : 2009-04-02

Export document
Format :
Citation style :